LysAla3Bradykinin CAS 103545182 China Suppliers Factory
High-purity Lys-Ala3-Bradykinin (CAS 103545-18-2) produced by leading China factory. As a selective B2 receptor agonist, this synthetic peptide is ideal for cardiovascular and inflammatory research. Contact our expert suppliers for pharmaceutical-grade quality and global delivery.
About this product
Product information from the supplier.
Lys-(Ala3)-Bradykinin (CAS NO. 103545-18-2) is a high-precision synthetic peptide analog designed as a potent and selective B2 receptor agonist. Engineered for advanced pharmacological research, this decapeptide features a strategic Ala3 substitution and N-terminal lysine extension, significantly enhancing its metabolic stability and receptor affinity compared to native Bradykinin. It serves as a critical tool for scientists investigating the kallikrein-kinin system, inflammatory pain pathways, and cardiovascular regulation.
By triggering intracellular signal transduction cascades via Gq/11 protein activation and phospholipase C (PLC) stimulation, this reagent enables the detailed study of calcium flux and the release of pro-inflammatory mediators. Ideal for in vitro laboratory research, receptor binding assays, and preclinical pharmacological studies, Lys-(Ala3)-Bradykinin provides the reliability and purity required for high-impact drug discovery and the development of novel modulators for inflammatory and cardiovascular disorders.
Detailed Parameters
| Product Name | Lys-(Ala3)-Bradykinin | CAS NO. | 103545-18-2 |
|---|---|---|---|
| Molecular Formula | C54H83N17O12 | Molecular Weight | 1162.37 g/mol |
| Purity (RP-HPLC) | ≥99.0% | Appearance | White to off-white lyophilized powder |
| Endotoxin | ≤0.5 EU/mg | Solubility | Soluble in water or dilute acetic acid |
| Storage Conditions | -20°C, dry, dark, well-sealed | Stock Location | USA |
Key Advantages
Ultra-High Purity
Guaranteed ≥99.0% purity via RP-HPLC, ensuring consistent and reproducible results in sensitive receptor binding assays.
Enhanced Stability
The Ala3 substitution confers superior metabolic resistance, prolonging interaction time with target receptors.
Selective Agonism
Acts as a highly selective B2 receptor probe, reducing off-target noise in GPCR signaling research.
Proven Efficacy
Validated in preclinical studies for inducing vascular relaxation and stimulating prostaglandin synthesis.
Rigorous QC
Each batch is accompanied by COA, HPLC purity reports, and MS chromatograms for full transparency.
Rapid Global Delivery
Strategically stocked in the USA and shipped via DHL/FedEx to ensure cold-chain integrity and speed.
Product Gallery
Management Platforms
GMP Production
Manufacturing follows strict GMP-compliant systems for high-grade pharmaceutical intermediates.
Quality Control
Standardized processes from raw material procurement to final peptide purification.
Batch Traceability
Full traceability data provided for every lot to ensure research consistency.
Cold-Chain Logistics
Professional secure packaging designed to prevent freeze-thaw degradation.
Scale Flexibility
Ability to supply from gram-level laboratory samples to ton-level industrial quantities.
Regulatory Compliance
Adherence to international trade standards and FDA/DMF certified partner laboratories.
Research Value Comparison
| Feature | Native Bradykinin | Lys-(Ala3)-Bradykinin |
|---|---|---|
| Metabolic Stability | Low (Rapidly degraded) | High (Resistant to ACE) |
| Receptor Selectivity | General B1/B2 | Selective B2 Agonist |
| Half-life in Assay | Short | Prolonged |
| Binding Affinity | Standard | Enhanced/Modified |
| Research Utility | Baseline Study | Advanced Mechanism Probe |
Frequently Asked Questions
It is primarily used as a selective B2 receptor agonist to study inflammatory pain, cardiovascular regulation, and G-protein coupled receptor (GPCR) signaling pathways in vitro.
The Ala3 substitution increases metabolic resistance, preventing rapid degradation by kinases such as ACE, thereby extending its functional lifespan during biological assays.
Each product is supplied with a Certificate of Analysis (COA), RP-HPLC purity report, and Mass Spectrometry (MS) chromatograms to ensure pharmaceutical-grade quality.
It must be stored at -20°C in a dry, dark, and well-sealed container. It is critical to avoid repeated freeze-thaw cycles to prevent degradation.
No, this product is strictly designated for in vitro laboratory research and preclinical pharmacological studies. It is not for clinical therapeutic use.
We utilize professional international air freight via DHL, FedEx, UPS, and TNT to ensure rapid transit and minimize environmental impact on the peptide's stability.